Structures by: Andrighetti-Fröhner C. R.
Total: 13
5-[(4-Methoxyphenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H15NO5
Acta Crystallographica Section E (2005) 61, 12 o4121-o4122
a=13.007(3)Å b=7.1317(14)Å c=14.743(3)Å
α=90.00° β=102.14(3)° γ=90.00°
5-[(2-Bromophenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C13H12BrNO4
Acta Crystallographica Section E (2005) 61, 12 o4252-o4253
a=6.960(5)Å b=9.298(5)Å c=10.424(5)Å
α=95.570(5)° β=101.043(5)° γ=99.508(5)°
5-[(4-Methylthiazol-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C11H12N2O4S
Acta Crystallographica Section E (2006) 62, 3 o1163-o1164
a=5.6384(6)Å b=18.562(4)Å c=11.920(2)Å
α=90.00° β=103.140(10)° γ=90.00°
5-(5-Ethyl-1,3,4-thiadiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane- 4,6-dione
C11H13N3O4S
Acta Crystallographica Section E (2006) 62, 4 o1520-o1521
a=10.733(2)Å b=9.8420(10)Å c=24.650(2)Å
α=90.00° β=90.00° γ=90.00°
1,3-Benzodioxol-5-ylmethaneammonium 2-methoxy-5-[(1<i>E</i>)-3-oxo-3-phenylprop-1-en-1-yl] bezenesulfonate monohydrate
C8H10NO2,C16H13O5S,H2O
Acta Crystallographica Section E (2006) 62, 7 o2785-o2787
a=11.6310(10)Å b=24.6860(10)Å c=8.1980(10)Å
α=90.00° β=90.00° γ=90.00°
Quinolin-8-yl 2,5-dichlorobenzenesulfonate
C15H9Cl2NO3S
Acta Crystallographica Section E (2006) 62, 6 o2104-o2105
a=7.8420(10)Å b=25.536(3)Å c=7.6420(10)Å
α=90.00° β=107.870(10)° γ=90.00°
5-(5-Bromothiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione ?
C10H9BrN2O4S
Acta Crystallographica Section E (2006) 62, 3 o1062-o1063
a=5.408(5)Å b=18.013(5)Å c=13.114(5)Å
α=90.00° β=100.717(5)° γ=90.00°
<i>N</i>-(4-Methoxybenzyl)quinoline-8-sulfonamide
C17H16N2O3S
Acta Crystallographica Section E (2007) 63, 7 o3059-o3059
a=7.2730(10)Å b=9.1460(10)Å c=22.975(3)Å
α=90.00° β=90.00° γ=90.00°
5-(2-Benzoylethenyl)-<i>N</i>-benzyl-2-methoxybenzenesulfonamide
C23H21NO4S
Acta Crystallographica Section E (2007) 63, 7 o3275-o3276
a=10.3671(12)Å b=10.3750(8)Å c=10.7977(14)Å
α=84.880(10)° β=68.790(10)° γ=65.400(10)°
Pyridinium 4-[(1<i>E</i>)-3-oxo-3-phenylprop-1-en-1-yl]benzenesulfonate
C5H6N,C15H11O4S
Acta Crystallographica Section E (2007) 63, 7 o3156-o3157
a=17.034(2)Å b=9.0682(9)Å c=11.832(2)Å
α=90.00° β=96.61(2)° γ=90.00°
<i>N</i>-(4-Methoxybenzyl)-3-[(1E)-3-oxo-3-phenylprop-1-en-1- yl]benzenesulfonamide
C24H23NO5S
Acta Crystallographica Section E (2007) 63, 8 o3437-o3438
a=10.7540(10)Å b=10.9500(10)Å c=11.307(2)Å
α=65.020(2)° β=65.64(2)° γ=85.92(2)°
8-(Piperidin-1-ylsulfonyl)quinoline
C14H16N2O2S
Acta Crystallographica Section E (2007) 63, 4 o1638-o1639
a=7.2682(7)Å b=14.319(2)Å c=14.411(2)Å
α=111.31(2)° β=101.490(10)° γ=100.710(10)°
N-Benzylquinoline-8-sulfonamide
C16H14N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3693-o3694
a=10.142(2)Å b=9.980(2)Å c=14.428(2)Å
α=90.00° β=100.25(2)° γ=90.00°